D-0576-2020 Class II Terminated
FDA drug recall D-0576-2020 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Dec 2, 2019 and is designated Class II. Reason for recall: Presence of Foreign Substance: Presence of a foreign object in a single tablet. The recall status is terminated (terminated Oct 14, 2021). Affected quantity: 1,824 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Dec 2, 2019
- Termination Date
- Oct 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,824 bottles
Product description
Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.
Reason for recall
Presence of Foreign Substance: Presence of a foreign object in a single tablet.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: NT119005A, Exp 07/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0576-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026